BIOMARIN PHARMACEUTICAL INC Number of Reportable Segments
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Number of Reportable Segments of 1 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-08-06
- BIOMARIN PHARMACEUTICAL INC number of reportable segments for fiscal 2021 was 1.00 Segment, a 0.00% change from fiscal 2020.
- BIOMARIN PHARMACEUTICAL INC number of reportable segments for fiscal 2020 was 1.00 Segment, a 0.00% change from fiscal 2019.
- BIOMARIN PHARMACEUTICAL INC number of reportable segments for fiscal 2019 was 1.00 Segment, a 0.00% change from fiscal 2018.
- BIOMARIN PHARMACEUTICAL INC number of reportable segments for fiscal 2018 was 1.00 Segment.
Segment
| Period end | Number of Reportable Segments 12 month |
|---|---|
| 2021-12-31 | 1.00 Segment 10-K · filed 2022-02-25 |
| 2020-12-31 | 1.00 Segment 10-K · filed 2021-02-26 |
| 2019-12-31 | 1.00 Segment 10-K · filed 2020-02-27 |
| 2018-12-31 | 1.00 Segment 10-K · filed 2019-02-28 |
segment
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 12 month |
|---|---|---|---|
| 2026-06-30 | 1.00 segment 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | 1.00 segment 10-Q · filed 2026-05-05 | ||
| 2025-12-31 | 1.00 segment 10-K · filed 2026-02-26 | ||
| 2023-12-31 | 1.00 segment 10-K · filed 2024-02-26 | ||
| 2022-12-31 | 1.00 segment 10-K · filed 2023-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |